Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W.

Glia. 2011 Jan;59(1):58-67. doi: 10.1002/glia.21076. Epub 2010 Sep 27.

2.

Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.

Li J, Ye L, Wang X, Hu S, Ho W.

J Neurosci Res. 2012 Feb;90(2):399-406. doi: 10.1002/jnr.22758. Epub 2011 Nov 4.

3.

Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells.

Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova JL, Studer L, Notarangelo LD.

Nature. 2012 Nov 29;491(7426):769-73. doi: 10.1038/nature11583. Epub 2012 Oct 28.

4.

IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Zhou L, Li J, Wang X, Ye L, Hou W, Ho J, Li H, Ho W.

J Neurovirol. 2011 Jun;17(3):212-9. doi: 10.1007/s13365-011-0031-8. Epub 2011 Apr 16.

5.

A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.

Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K, Craigon MH, Chen R, Kaza LN, Fossum E, Fazakerley JK, Efstathiou S, Volpi A, Zimmer R, Ghazal P, Haas J.

PLoS Pathog. 2013;9(8):e1003514. doi: 10.1371/journal.ppat.1003514. Epub 2013 Aug 8.

6.

A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells.

Furr SR, Chauhan VS, Moerdyk-Schauwecker MJ, Marriott I.

J Neuroinflammation. 2011 Aug 12;8:99. doi: 10.1186/1742-2094-8-99.

7.

Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis.

Rosato PC, Leib DA.

PLoS Pathog. 2015 Jul 8;11(7):e1005028. doi: 10.1371/journal.ppat.1005028. eCollection 2015 Jul.

8.

Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK.

J Neurovirol. 2001 Jun;7(3):208-19.

PMID:
11517395
9.

TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice.

Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, Ulhøi BP, Holm TH, Mogensen TH, Owens T, Nyengaard JR, Thomsen AR, Paludan SR.

J Clin Invest. 2012 Apr;122(4):1368-76. doi: 10.1172/JCI60893. Epub 2012 Mar 19.

10.

Lambda-Interferons Inhibit Herpes Simplex Virus Type 2 Replication in Human Cervical Epithelial Cells by Activating the JAK/STAT Pathway.

Li Z, Lu X, Zhu Y, Cheng P, Liu S, Zhang Y, Tang J, Yang S, Zhou L.

Jpn J Infect Dis. 2017 Jul 24;70(4):416-422. doi: 10.7883/yoken.JJID.2016.465. Epub 2017 Feb 28.

11.

Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication.

Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Fujii N.

Virology. 2005 Jul 20;338(1):173-81.

12.

Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.

Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP.

J Gen Virol. 2005 Sep;86(Pt 9):2421-32.

13.

Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells.

Zhou Y, Ye L, Wan Q, Zhou L, Wang X, Li J, Hu S, Zhou D, Ho W.

J Neurosci Res. 2009 Oct;87(13):2916-25. doi: 10.1002/jnr.22110.

14.

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, Rice CM.

Gastroenterology. 2006 Dec;131(6):1887-98. Epub 2006 Oct 1.

PMID:
17087946
15.

Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS.

Reinert LS, Lopušná K, Winther H, Sun C, Thomsen MK, Nandakumar R, Mogensen TH, Meyer M, Vægter C, Nyengaard JR, Fitzgerald KA, Paludan SR.

Nat Commun. 2016 Nov 10;7:13348. doi: 10.1038/ncomms13348.

16.

Interferon lambda inhibits dengue virus replication in epithelial cells.

Palma-Ocampo HK, Flores-Alonso JC, Vallejo-Ruiz V, Reyes-Leyva J, Flores-Mendoza L, Herrera-Camacho I, Rosas-Murrieta NH, Santos-López G.

Virol J. 2015 Sep 28;12:150. doi: 10.1186/s12985-015-0383-4.

18.
19.

Antiviral effect of interferon lambda against West Nile virus.

Ma D, Jiang D, Qing M, Weidner JM, Qu X, Guo H, Chang J, Gu B, Shi PY, Block TM, Guo JT.

Antiviral Res. 2009 Jul;83(1):53-60. doi: 10.1016/j.antiviral.2009.03.006. Epub 2009 Apr 1.

20.

Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection.

Zimmer B, Ewaleifoh O, Harschnitz O, Lee YS, Peneau C, McAlpine JL, Liu B, Tchieu J, Steinbeck JA, Lafaille F, Volpi S, Notarangelo LD, Casanova JL, Zhang SY, Smith GA, Studer L.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8775-E8782. doi: 10.1073/pnas.1809853115. Epub 2018 Aug 28.

PMID:
30154162

Supplemental Content

Support Center